Structured Testing and Treatment for Obstructive Sleep Apnea in Patients With Atrial Fibrillation

Recruiting N/A Interventional Study
Atrial Fibrillation Obstructive Sleep Apnea
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
209 (estimated)
Sponsor
University Hospital, Antwerp · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The main goal of this prospective pre-post implementation study is to investigate how a structured testing and treatment program for obstructive sleep apnea using the NOX T3s device and a Fitbit smartwatch with the FibriCheck algorithm impacts the proportion of atrial fibrillation (AF) in an AF population. Participants will wear the NOX T3s respiratory polygraphy device for one night at home. In …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients in whom AF (paroxysmal or persistent) is diagnosed with a 12-lead ECG * Patients who experience symptoms of their AF (mEHRA ≥ 2a) * Older than 18 years * Owning a smartphone compatible with Fitbit and FibriCheck applications (i.e. recent versions of Apple iOS or Andro…
Contacts

Lien Desteghe, MSc, PhD

+32 3 821 33 06

lien.desteghe@uza.be

CONTACT